These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38232937)

  • 21. Phase 1/2 Trial of 5-Fraction Stereotactic Radiosurgery With 5-mm Margins With Concurrent and Adjuvant Temozolomide in Newly Diagnosed Supratentorial Glioblastoma: Health-Related Quality of Life Results.
    Pollom EL; Fujimoto D; Wynne J; Seiger K; Modlin LA; Jacobs LR; Azoulay M; von Eyben R; Tupper L; Gibbs IC; Hancock SL; Li G; Chang SD; Adler JR; Harsh GR; Harraher C; Nagpal S; Thomas RP; Recht LD; Choi CYH; Soltys SG
    Int J Radiat Oncol Biol Phys; 2017 May; 98(1):123-130. PubMed ID: 28586949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Image-Guided, Linac-Based, Surgical Cavity-Hypofractionated Stereotactic Radiotherapy in 5 Daily Fractions for Brain Metastases.
    Soliman H; Myrehaug S; Tseng CL; Ruschin M; Hashmi A; Mainprize T; Spears J; Das S; Yang V; da Costa L; Maralani P; Heyn C; Atenafu EG; Sahgal A
    Neurosurgery; 2019 Nov; 85(5):E860-E869. PubMed ID: 31173150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subventricular zone involvement at recurrence is a strong predictive factor of outcome following high grade glioma reirradiation.
    Attal J; Chaltiel L; Lubrano V; Sol JC; Lanaspeze C; Vieillevigne L; Latorzeff I; Cohen-Jonathan Moyal E
    J Neurooncol; 2018 Jan; 136(2):413-419. PubMed ID: 29273890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjuvant stereotactic fractionated radiotherapy to the resection cavity in recurrent glioblastoma - the GlioCave study (NOA 17 - ARO 2016/3 - DKTK ROG trial).
    Straube C; Scherb H; Gempt J; Kirschke J; Zimmer C; Schmidt-Graf F; Meyer B; Combs SE
    BMC Cancer; 2018 Jan; 18(1):15. PubMed ID: 29298660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vestibular Schwannoma Hypofractionated Stereotactic Radiation Therapy in Five Fractions.
    Gawish A; Walke M; Röllich B; Ochel HJ; Brunner TB
    Clin Oncol (R Coll Radiol); 2023 Jan; 35(1):e40-e47. PubMed ID: 36335041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Re-Irradiation and Its Contribution to Good Prognosis in Recurrent Glioblastoma Patients.
    Kim MS; Lim J; Shin HS; Cho KG
    Brain Tumor Res Treat; 2020 Apr; 8(1):29-35. PubMed ID: 32390351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypofractionated Stereotactic Radiation Therapy for Intact Brain Metastases in 5 Daily Fractions: Effect of Dose on Treatment Response.
    Myrehaug S; Hudson J; Soliman H; Ruschin M; Tseng CL; Detsky J; Husain Z; Keith J; Atenafu EG; Maralani P; Heyn C; Das S; Lipsman N; Sahgal A
    Int J Radiat Oncol Biol Phys; 2022 Feb; 112(2):342-350. PubMed ID: 34537313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypofractionated stereotactic radiotherapy for brain metastases larger than three centimeters.
    Jiang XS; Xiao JP; Zhang Y; Xu YJ; Li XP; Chen XJ; Huang XD; Yi JL; Gao L; Li YX
    Radiat Oncol; 2012 Mar; 7():36. PubMed ID: 22429918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stereotactic Radiotherapy in Recurrent Glioblastoma: A Valid Salvage Treatment Option.
    Yaprak G; Isık N; Gemici C; Pekyurek M; Ceylaner Bıcakcı B; Demircioglu F; Tatarlı N
    Stereotact Funct Neurosurg; 2020; 98(3):167-175. PubMed ID: 32248188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carotid Dosimetry and the Risk of Carotid Blowout Syndrome After Reirradiation With Head and Neck Stereotactic Body Radiation Therapy.
    Gebhardt BJ; Vargo JA; Ling D; Jones B; Mohney M; Clump DA; Ohr JP; Ferris RL; Heron DE
    Int J Radiat Oncol Biol Phys; 2018 May; 101(1):195-200. PubMed ID: 29398127
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Salvage reirradiation for recurrent glioblastoma with radiosurgery: radiographic response and improved survival.
    Patel M; Siddiqui F; Jin JY; Mikkelsen T; Rosenblum M; Movsas B; Ryu S
    J Neurooncol; 2009 Apr; 92(2):185-91. PubMed ID: 19066727
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypofractionated Stereotactic Radiation Therapy in Recurrent High-Grade Glioma: A New Challenge.
    Navarria P; Ascolese AM; Tomatis S; Reggiori G; Clerici E; Villa E; Maggi G; Bello L; Pessina F; Cozzi L; Scorsetti M
    Cancer Res Treat; 2016 Jan; 48(1):37-44. PubMed ID: 25761491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival following CyberKnife radiosurgery and hypofractionated radiotherapy for newly diagnosed glioblastoma multiforme.
    Lipani JD; Jackson PS; Soltys SG; Sato K; Adler JR
    Technol Cancer Res Treat; 2008 Jun; 7(3):249-55. PubMed ID: 18473497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial.
    Malmström A; Grønberg BH; Marosi C; Stupp R; Frappaz D; Schultz H; Abacioglu U; Tavelin B; Lhermitte B; Hegi ME; Rosell J; Henriksson R;
    Lancet Oncol; 2012 Sep; 13(9):916-26. PubMed ID: 22877848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term clinical outcomes of hypofractionated stereotactic radiotherapy using the CyberKnife robotic radiosurgery system for jugular foramen schwannomas.
    Zou W; Guan Y; Zhu H; Gong X; Wang E; Yao C; Wang X
    J Neurosurg; 2024 May; 140(5):1254-1261. PubMed ID: 37976497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of patients with recurrent glioblastoma using hypofractionated stereotactic radiotherapy.
    Dincoglan F; Beyzadeoglu M; Sager O; Demiral S; Gamsiz H; Uysal B; Ebruli C; Akin M; Oysul K; Sirin S; Dirican B
    Tumori; 2015; 101(2):179-84. PubMed ID: 25791534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme.
    Prados MD; Wara WM; Sneed PK; McDermott M; Chang SM; Rabbitt J; Page M; Malec M; Davis RL; Gutin PH; Lamborn K; Wilson CB; Phillips TL; Larson DA
    Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):71-7. PubMed ID: 11163499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined stereotactic split-course fractionated gamma knife radiosurgery and conventional radiation therapy for unfavorable gliomas: a phase I study.
    Regine WF; Patchell RA; Strottmann JM; Meigooni A; Sanders M; Young B
    J Neurosurg; 2000 Dec; 93 Suppl 3():37-41. PubMed ID: 11143260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Re-irradiation for recurrent glioblastoma (GBM): a systematic review and meta-analysis.
    Kazmi F; Soon YY; Leong YH; Koh WY; Vellayappan B
    J Neurooncol; 2019 Mar; 142(1):79-90. PubMed ID: 30523605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival benefits of hypofractionated radiotherapy combined with temozolomide or temozolomide plus bevacizumab in elderly patients with glioblastoma aged ≥ 75 years.
    Ohno M; Miyakita Y; Takahashi M; Igaki H; Matsushita Y; Ichimura K; Narita Y
    Radiat Oncol; 2019 Nov; 14(1):200. PubMed ID: 31718669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.